Back

Evaluation of the antibody response and adverse reactions of the BNT162b2 vaccine of participants with prior COVID-19 infection in Japan

2021-07-22 infectious diseases Title + abstract only
View on medRxiv
Show abstract

IntroductionVaccination programs are important to preventing COVID-19 infection. BNT162b2 is new type of vaccine, and previous studies have shown that the antibody response was significantly elevated in patients with prior COVID-19 infection after the first vaccination. However, no study has evaluated the efficacy of the vaccination or the adverse reactions of people with prior COVID-19 infection in Japan. The aim of this study is to evaluate the antibody titer and adverse reactions of BNT162b2 ...

Predicted journal destinations

1
Vaccines
131 training papers
#1 30.4%
2
PLOS ONE
1737 training papers
Top 59% 9.6%
3
Vaccine
140 training papers
Top 1% 8.3%
4
International Journal of Infectious Diseases
115 training papers
Top 2% 4.4%
5
Clinical Infectious Diseases
219 training papers
Top 12% 3.3%
6
Frontiers in Medicine
99 training papers
Top 7% 2.1%
7
Scientific Reports
701 training papers
Top 78% 2.1%
8
The Lancet Infectious Diseases
57 training papers
Top 1% 2.1%
9
Frontiers in Public Health
135 training papers
Top 14% 2.1%
10
Journal of Medical Virology
95 training papers
Top 5% 2.1%
11
Open Forum Infectious Diseases
124 training papers
Top 8% 1.6%
12
BMJ Open
553 training papers
Top 53% 1.6%
13
Frontiers in Immunology
140 training papers
Top 8% 1.4%
14
Heliyon
57 training papers
Top 4% 1.4%
15
The Journal of Infectious Diseases
137 training papers
Top 12% 1.3%
16
Clinical Microbiology and Infection
54 training papers
Top 5% 1.2%
17
BMC Infectious Diseases
110 training papers
Top 20% 1.0%
18
JAMA Network Open
125 training papers
Top 22% 1.0%
19
New England Journal of Medicine
49 training papers
Top 4% 0.8%
20
Human Vaccines & Immunotherapeutics
20 training papers
Top 0.6% 0.8%
21
Journal of Infection
64 training papers
Top 10% 0.8%
22
Emerging Infectious Diseases
84 training papers
Top 16% 0.8%
23
Eurosurveillance
77 training papers
Top 13% 0.8%